INS and neoplasm: While insulin-target organs are resistant to the actions of insulin in diabetes, hyperinsulinemia may have progrowth effects on a nascent tumour by allowing the tumour to overcome an important early barrier in tumourigenesis, that is, lack of growth factor signaling.